Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to develop and test the feasibility of a new therapy called Compassion Focused Therapy (CFT) for psychosis. This therapy helps people with psychosis manage distressing experiences by building internal feelings of safeness and affiliation, and by providing contexts, practices and insights that facilitate the development of compassion to self and others. The focus is on helping people feel safe in relation to their experiences and their social worlds. CFT is a promising new approach that has been successfully provided for people with a range of mental health difficulties. It is also firmly based in the most up-to-date knowledge and science about how the mind works (both normally and under stress).
9 participants will be recruited from NHS psychological therapies services for people with psychosis in South London and Maudsley (SLAM) NHS Foundation Trust. Following a short baseline period they will receive up to 26 weekly sessions (about 6 months) of CFT with a clinical psychologist, and will provide interview and questionnaire research data at five different points during the study. At these assessment points, data will be gathered on participants' experiences, mood, perceptions of their position in the social world, and heart rate variability.
The initial therapy protocol has been developed by psychologists with expertise in CFT, alongside people with lived experience of hearing voices and having distressing beliefs. However, it will continue to be developed and evolve as the study progresses, and as more is learnt (e.g. from the service-user participants) about applying the model in this population. At the end of this study, the aim is to have all the information needed to run a randomised controlled trial of this therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Compassion Focused Therapy | Other | Intervention |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Compassion Focused Therapy | Other | Up to 26 sessions of Compassion Focused Therapy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Attrition rate measured by number dropping out of therapy | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Psychotic symptoms measured by PSYRATS | Measured by PSYRATS (Psychotic Symptom Rating Scales) | Over 6 months of therapy, and 6-8 weeks post-therapy |
| Depression and anxiety symptoms measured by DASS-21 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Charlie Heriot-Maitland, DClinPsych | King's College London | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| South London and Maudsley NHS Foundation Trust | London | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D011618 | Psychotic Disorders |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Measured by DASS-21 (Depression, Anxiety and Stress Scale)
| Over 6 months of therapy, and 6-8 weeks post-therapy |
| Subjective wellbeing, symptoms, functioning, and risk/harm measured by CORE | Measured by CORE (Clinical Outcomes in Routine Evaluation) | Over 6 months of therapy, and 6-8 weeks post-therapy |
| Dissociative experiences measured by DES-II | Measured by DES-II (Dissociative Experiences Scale) | Over 6 months of therapy, and 6-8 weeks post-therapy |